X0609 4 2026-09-17 0001830487 Pharvaris N.V. PHVS 0001810406 Bjork Elisabeth false 1 CRANBERRY HILL SUITE 400 LEXINGTON MA 02421 true false false false false Common Stock 2026-09-17 4 M false 35000 14.39 A 50167 D Common Stock 2026-09-17 4 M false 17500 18.14 A 67667 D Common Stock 2026-09-17 4 S false 52500 37.8935 D 15167 D Stock Option (Right to Buy) 14.39 2026-09-17 4 M false 35000 0 D 2032-01-01 Common Stock 35000 0 D Stock Option (Right to Buy) 18.14 2026-09-17 4 M false 17500 0 D 2032-04-01 Common Stock 17500 0 D The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date. The shares were sold in connection with the exercise of stock options in a cashless exercise transaction. The sales prices for the transactions ranged from $37.62 to $38.05. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. 25% of the option vested on January 1, 2023 with the remaining shares vesting in 1/48 monthly installments thereafter. 25% of the option vested on April 1, 2023 with the remaining shares vesting in 1/48 monthly installments thereafter. /s/ Marnus Nel, Attorney-in-Fact for Elisabeth Bjork 2026-09-21